Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 16 (21)

Cannabis and Psychosis Through the Lens of DSM-5

Affiliations
Review

Cannabis and Psychosis Through the Lens of DSM-5

Nathan T Pearson et al. Int J Environ Res Public Health.

Abstract

Evidence for an association between cannabis and psychosis has been documented in literature in many forms including experimental studies, epidemiological data, and case series. The association has implications for psychotic outcomes ranging from mild to severe and occurring over minutes to years. Due to the huge variety of exposures and outcome measures reported, creating a coherent account of all the available information is difficult. A useful way to conceptualize these wide-ranging results is to consider the association between cannabis and psychosis as it occurs within the context of widely used DSM-5 diagnoses. In the present review we examine cannabis/psychosis associations as they pertain to Cannabis Intoxication, Cannabis-Induced Psychotic Disorder, and Schizophrenia. This allows for an understanding of the cannabis and psychosis association along something approaching a continuum. Cannabis intoxication becomes Cannabis-Induced Psychotic Disorder once certain severity and duration criteria are met and Cannabis-Induced Psychotic Disorder is heavily associated with future schizophrenia diagnoses.

Keywords: DSM-5; cannabis; delusions; hallucinations; intoxication; marijuana; paranoia; psychosis; schizophrenia.

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

References

    1. United Nations Publication . World Drug Report 2018. United Nations Publication; New York, NY, USA: 2018.
    1. Rong C., Lee Y., Carmona N.E., Cha D.S., Ragguett R.M., Rosenblat J.D., Mansur R.B., Ho R.C., McIntyre R.S. Cannabidiol in medical marijuana: Research vistas and potential opportunities. Pharmacol. Res. 2017;121:213–218. doi: 10.1016/j.phrs.2017.05.005. - DOI - PubMed
    1. Hasin D.S., Sarvet A.L., Cerda M., Keyes K.M., Stohl M., Galea S., Wall M.M. US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991–1992 to 2012–2013. JAMA Psychiatry. 2017;74:579–588. doi: 10.1001/jamapsychiatry.2017.0724. - DOI - PMC - PubMed
    1. Carliner H., Brown Q.L., Sarvet A.L., Hasin D.S. Cannabis use, attitudes, and legal status in the US: A review. Prev. Med. 2017;104:13–23. doi: 10.1016/j.ypmed.2017.07.008. - DOI - PMC - PubMed
    1. Russo E.B., Marcu J. Cannabis pharmacology: The usual suspects and a few promising leads. Adv. Pharmacol. 2017;80:67–134. doi: 10.1016/bs.apha.2017.03.004. - DOI - PubMed
Feedback